Grantham, Mayo, Van Otterloo & Co (GMO)
MNDT

Grantham, Mayo, Van Otterloo & Co (GMO)’s Mandiant, Inc. Common Stock MNDT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MNDT Stock Details MNDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,743,150
Closed -$38M – 817
2022
Q2 		$38M Buy
1,743,150
+158,623
+10% +$3.48M 0.21% 90
2022
Q1 		$35.4M Buy
+1,584,527
New +$29.3M 0.17% 97

Other funds holding MNDT

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MNDT Position: Q3 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Mandiant, Inc. Common Stock (MNDT) in Q3 2022, closing a stake of 1,743,150 shares — an estimated $38M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MNDT in Q1 2022 and held it in 2 quarters. The position peaked at $38M in Q2 2022. 3 funds tracked by Wall St. Rank hold MNDT as of Q3 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Mandiant, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,743,150 Mandiant, Inc. Common Stock shares in Q3 2022, an estimated $38M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Mandiant, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Mandiant, Inc. Common Stock position peaked at $38M in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q3 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.